Author

Samit Ghosal

ENDOCRINOLOGIST - Cited by 1,667 - Diabetes & Endocrinology

Biography

Dr. Samit GhosalMBBS, MD - Internal Medicine, Post Graduate Diploma in Endocrinology, Post Graduate Diploma in Diabetology (PGDD)(Madras Medical College)23 years experience. Awards: 1. Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors – A survey" 2. Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
Title
Cited by
Year
Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: a …
S Ghosal, B Sinha, M Majumder, A MisraDiabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (4), 319-323, 2020202
216
2020
Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases-March 14th 2020)
S Ghosal, S Sengupta, M Majumder, B SinhaDiabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (4), 311-315, 2020202
134
2020
Impact of complete lockdown on total infection and death rates: A hierarchical cluster analysis
S Ghosal, R Bhattacharyya, M MajumderDiabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (4), 707-711, 2020202
88
2020
Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: a cohort analysis
S Ghosal, B Arora, K Dutta, A Ghosh, B Sinha, A MisraDiabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (5), 949-952, 2020202
84
2020
A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)
S Ghosal, D Datta, B SinhaScientific Reports 11 (1), 22063, 2021202
34
2021
The effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on death and severity of disease in patients with coronavirus disease 2019 (COVID-19 …
S Ghosal, JJ Mukherjee, B Sinha, K GangopadhyaymedRxiv, 2020.04. 23.20076661, 2020202
32
2020
Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials
B Sinha, S GhosalScientific Reports 10 (1), 15781, 2020202
22
2020
The role of corticosteroids in the management of critically ill patients with coronavirus disease 2019 (COVID-19): A meta-analysis
The role of corticosteroids in the management of critically ill patients with coronavirus disease 20 (COVID-): A meta-analysisKK Gangopadhyay, JJ Mukherjee, B Sinha, S GhosalMedRxiv, 2020.04. 17.20069773, 2020202
19
2020
Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors–A survey
KK Gangopadhyay, B Sinha, S GhosalDiabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (5), 1413-1418, 2020202
10
2020
Quantitative measure of asymptomatic cardiovascular disease risk in Type 2 diabetes: Evidence from Indian outpatient setting
S Ghosal, B Sinha, J Ved, M BiswasIndian Heart Journal 72 (2), 11-122, 2020202
9
2020
Frequency of testing for COVID 19 infection and the presence of higher number of available beds per country predict outcomes with the infection, not GDP of the country–A …
Frequency of testing for COVID 1 infection and the presence of higher number of available beds per country predict outcomes with the infection, not GDP of the country–A …B Sinha, S Sengupta, S GhosalmedRxiv, 2020.04. 01.20047373, 2020202
9
2020
Diabetes and musculoskeletal disorders-a review
S Ghosal, A GhosalJournal of Diabetes, Metabolic Disorders & Control 7 (2), 63-71, 2020202
9
2020
Meta‐analysis of the effects of sodium glucose cotransporter 2 inhibitors in non‐alcoholic fatty liver disease patients with type 2 diabetes
B Sinha, D Datta, S GhosalJGH Open 5 (2), 219-227, 2021202
8
2021
A Meta-Analysis of the Effect of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic Parameters in Patients With Polycystic Ovary Syndrome
B Sinha, S GhosalFrontiers in endocrinology 13, 830401, 2022202
6
2022
A target HbA1c between 7 and 7.7% reduces microvascular and macrovascular events in T2D regardless of duration of diabetes: a meta-analysis of randomized controlled trials
B Sinha, S GhosalDiabetes Therapy 12 (6), 1661-1676, 2021202
4
2021
Mobile health (mhealth) to improve quality of life in breast cancer survivors: study protocol for randomized controlled trial
M Kaur, BS Yadav, D Dahiya, A Akhilesh, S Kaur, S Ghosal, S GhaiEuropean Journal of Cancer 18, S91, 2020202
3
2020
The cardiovascular benefits of GLP1-RAs are related to their positive effect on glycemic control: A meta-regression analysis
S Ghosal, B SinhaDiabetes Research and Clinical Practice 186, 109824, 2022202
3
2022
Reply to letter to the editor regarding article: Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and …
S GhosalDiabetes & Metabolic Syndrome 14 (4), 449, 000
2
2020
Redefining cardiovascular (CV) death as a primary endpoint component in cardiovascular outcome trials
S Ghosal, B SinhaCurrent Diabetes Reviews 16 (9), 917-91, 000
2
2020
No role of HCQ in COVID-19 prophylaxis: a survey amongst Indian doctors
No role of HCQ in COVID-9 prophylaxis: a survey amongst Indian doctorsD Datta, S Ghosal, B Sinha, S Datta, T Chakraborty, KK GangopadhyayJ Vaccines Vaccin 6, 002, 2020202
1
2020

Referred From: https://scholar.google.co.in/citations?user=oYm-sp4AAAAJ&hl=en

Cited by
Citations 1667
h-index 19
i10-index 25
Recommended Journals
Open Access Journals